QTI Utang marang Ekuitas qtimaging.com

Logo korporat perusahaan QT Imaging, Inc. (QTI)

QT Imaging Holdings, Inc. (QTI) develops high-tech 3D ultrasound systems for early-stage breast tumor detection, leveraging substantial investments in engineering R&D. This chart of historical total debt-to-equity ratios is fixed at 7.15. Demand for non-contact screening is rising, and the expansion potential within the diagnostic center segment remains significant. The method's efficacy is validated by partnerships with oncology centers through joint scientific projects.

QTI: Rasio Total Utang marang Ekuitas qtimaging.com 06.03.2024 - 01.11.2026

QT Imaging, Inc. - rincian analitis lan metrik utama (QTI)

- rega saham lan konsensus proyeksi valuasi:
Rega saham QT Imaging|QTI - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar QT Imaging|QTI - Nilai Bisnis
- rincian nilai buku perusahaan:
Nilai Buku saben Saham QT Imaging|QTI - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku qtimaging.com|QTI - Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas QT Imaging Holdings, Inc.|QTI - Koefisien utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas QT Imaging Holdings, Inc.|QTI - Kewajiban utang agregat|Utang marang nilai buku QT Imaging|QTI - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan QT Imaging|Likuiditas cepet qtimaging.com
- informasi bathi lan kelipatan valuasi:
QTI - Penghasilan resik
Pambiji fundamental perusahaan:QT Imaging
Barang utama qtimaging.com

This ratio compares total credit obligations to the amount of equity, determining the degree of financial leverage and the balance sheet's resilience to external shocks. By analyzing the capital structure—the debt-to-equity ratio—an investor can assess the extent to which QT Imaging Holdings, Inc. (QTI) management's strategy for ensuring patent protection and FDA compliance relies on borrowed resources or internal reserves.

Analisis perusahaan pesaing

MRUS (Merus) - Total Utang marang Modal|Total Utang marang Modal Immutep Ltd|Utang marang Ekuitas Anixa Biosciences Inc (ANIX)|Atossa Pharma - Rasio Utang marang Ekuitas|Total Utang marang Modal CNTX (Context Therapeutics Inc.)|MRSN - Rasio Total Utang marang Ekuitas|BriaCell - Total Utang marang Modal|Utang marang Modal ESSA Pharma Inc.